Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Vermillion Reports Financial Results for the Third Quarter 2010

November 11, 2010 By Bio-Medicine.Org

AUSTIN, Texas, Nov. 11, 2010 /PRNewswire-FirstCall/ —
Vermillion, Inc. (Nasdaq:
VRML
), a molecular diagnostics company, today reported
financial results for the third quarter ended
September 30, 2010. Key milestones achieved since our
last quarterly conference call include:

Performed 1,973 OVA1 tests during the quarter, representing volume
growth of 74.4% over the second quarter of 2010; we recognized
product revenue from 1,250 tests in the third quarter of 2010
Extended Strategic Alliance agreement with Quest Diagnostics which
includes a more favorable revenue split for Vermillion; payment
will consist of a fixed upfront payment per test performed and a
royalty based on Quest Diagnostics gross profit for OVA1 Achieved
CE mark for OVA1, a requirement for marketing the test in the
European Union Presented OVA1 high sensitivity data by Dr. Fred
Ueland, Markey Cancer Center, University of Kentucky at the 13th
Annual International Gynecologic Cancer Society Meeting in Prague
Initiated an intended use study for our VASCLIR™ test for
peripheral artery disease (PAD) in October; this study is designed
to allow us to finalize the VASCLIR algorithm Received a notice of
allowance from the United States Patent and Trademark Office
(USPTO) for our patent entitled “B2-microglobulin as a biomarker
for peripheral artery disease” Received $489,000 in Therapeutic
Discovery Project tax credits, $244,479 for each of the OVA2™
and VASCLIR programs

“We are very pleased with our progress towards achieving
multiple key strategic and operational milestones in the third
quarter. Most importantly, our launch of OVA1 continues to show
strong physician adoption, with a 74 percent increase in volume
compared to the second quarter.  We also extended our
Strategic Alliance agreement with Quest Diagnostics to pro

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech